Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SULFADIAZINE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 6 adverse event reports in the FDA FAERS database where SULFADIAZINE was used for Psoriasis.

Most Reported Side Effects for SULFADIAZINE

Side Effect Reports % Deaths Hosp.
Drug hypersensitivity 228 26.9% 4 22
Condition aggravated 122 14.4% 44 82
Dyspnoea 115 13.6% 37 64
Therapeutic product effect incomplete 101 11.9% 35 62
Neurological symptom 96 11.3% 37 64
Pain in extremity 95 11.2% 36 63
Pulmonary fibrosis 95 11.2% 37 63
Asthma 94 11.1% 37 63
Pulmonary alveolar haemorrhage 94 11.1% 37 62
Haemoptysis 93 11.0% 37 62
Lung disorder 93 11.0% 37 62
Neuritis 93 11.0% 37 62
Obstructive airways disorder 93 11.0% 37 62
Pulmonary vasculitis 93 11.0% 36 61
Anxiety 92 10.9% 37 60

Other Indications for SULFADIAZINE

Product used for unknown indication (392) Cerebral toxoplasmosis (96) Toxoplasmosis (78) Ill-defined disorder (27) Rheumatoid arthritis (22) Eye infection toxoplasmal (19) Acanthamoeba infection (16) Pneumonia (13) Congenital toxoplasmosis (12) Prophylaxis (11)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

SULFADIAZINE Full Profile All Psoriasis Drugs SULFADIAZINE Demographics SULFADIAZINE Timeline